Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,196 | 123,080 | 35,965 | 71,308 | 495,729 |
| Marketable Securities | 73,442 | 262,293 | 354,939 | 369,933 | 52,368 |
| Receivables | 33,850 | 40,765 | 6,851 | 1,419 | 876 |
| TOTAL | $350,250 | $431,876 | $406,835 | $447,205 | $553,876 |
| Non-Current Assets | |||||
| PPE Net | 1,370 | 1,849 | 2,098 | 2,089 | 2,283 |
| Investments And Advances | 0 | 35,470 | 27,026 | 142,935 | 67,097 |
| Other Non-Current Assets | 12,775 | 14,639 | 16,430 | 18,154 | 19,814 |
| TOTAL | $14,145 | $51,958 | $45,554 | $163,178 | $89,194 |
| Total Assets | $364,395 | $483,834 | $452,389 | $610,383 | $643,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,871 | 4,002 | 4,698 | 2,784 | 1,741 |
| Accrued Expenses | 32,674 | 39,501 | 30,967 | 21,633 | 12,853 |
| TOTAL | $38,625 | $45,428 | $37,442 | $26,054 | $16,099 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 288,560 | 367,538 | 326,844 | 322,226 | 270,543 |
| TOTAL | $288,560 | $367,538 | $326,844 | $322,226 | $270,543 |
| Total Liabilities | $327,185 | $412,966 | $364,286 | $348,280 | $286,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,748 | 30,667 | 26,763 | 27,931 | 27,672 |
| Common Shares | 28 | 30 | 27 | 29 | 28 |
| Retained earnings | -772,559 | -759,327 | -614,096 | -450,477 | -321,753 |
| Other shareholders' equity | -24 | 305 | -797 | -5,246 | -422 |
| TOTAL | $37,210 | $70,868 | $88,103 | $262,103 | $356,428 |
| Total Liabilities And Equity | $364,395 | $483,834 | $452,389 | $610,383 | $643,070 |